Development of a validated patient-reported symptom metric for pediatric Eosinophilic Esophagitis: Qualitative methods

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Franciosi, James P ^a   Hommel, Kevin A ^a   DeBrosse, Charles W ^a   Greenberg, Allison B ^a   Greenler, Alexandria J ^a   Abonia, J Pablo ^a   Rothenberg, Marc E ^a   Varni, James W ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTENT VALIDITY; CONTROLLED STUDY; CUSTODY; DISEASE CLASSIFICATION; EOSINOPHILIC ESOPHAGITIS; FEMALE; HUMAN; INTERVIEW; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; VALIDATION PROCESS; HOSPITALIZATION; PARENT; QUALITATIVE RESEARCH; VALIDATION STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EOSINOPHILIC ESOPHAGITIS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; PARENTS; QUALITATIVE RESEARCH; QUESTIONNAIRES; SELF REPORT; SEVERITY OF ILLNESS INDEX;

EID: 81255172237     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-126     Document Type: Article

References (29)

1. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133(4):1342-1363. 10.1053/j.gastro.2007.08.017, 17919504.
2. Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK, Akers R, Cohen MB, Collins MH, Assa'ad AH, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006, 131(5):1381-1391. 10.1053/j.gastro.2006.08.033, 17101314.
3. Aceves SS, Newbury RO, Dohil MA, Bastian JF, Dohil R. A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. Ann Allergy Asthma Immunol 2009, 103(5):401-406. 10.1016/S1081-1206(10)60359-6, 19927538.
4. Klinnert MD. Psychological impact of eosinophilic esophagitis on children and families. Immunol Allergy Clin North Am 2009, 29(1):99-107. x, 10.1016/j.iac.2008.09.011, 19141345.
5. Rothenberg ME, Pentiuk S, Putnam PE, Collins MH. Dissociation Between Symptoms and Histological Severity in Pediatric Eosinophilic Esophagitis. J Pediatr Gastr Nutr 2009, 48(2):152-160.
6. Pedersen S, Potter P, Dachev S, Bosheva M, Kaczmarek J, Springer E, Dunkel J, Engelstatter R. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study. Respir Med 2010, 104(11):1618-1628. 10.1016/j.rmed.2010.06.012, 20619624.
7. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007, 45(5 Suppl 1):S3-S11.
8. DeWalt DA, Rothrock N, Yount S, Stone AA. Evaluation of item candidates: the PROMIS qualitative item review. Med Care 2007, 45(5 Suppl 1):S12-21. 2810630, 17443114.
9. Aletaha D. From the item to the outcome: the promising prospects of PROMIS. Arthritis Res Ther 2010, 12(1):104.. 10.1186/ar2910, 2875637, 20156319.
10. Einav S, Hersch M. The "PrOMIS" of things to come. Crit Care Med 2007, 35(4):1193-1194. 10.1097/01.CCM.0000259486.28416.EC, 17413785.
11. Fries JF, Krishnan E, Bruce B. Items, Instruments, Crosswalks, and PROMIS. J Rheumatol 2009, 36(6):1093-1095. 10.3899/jrheum.090320, 19509084.
12. Walsh TR, Irwin DE, Meier A, Varni JW, DeWalt DA. The use of focus groups in the development of the PROMIS pediatrics item bank. Quality of Life Research 2008, 17(5):725-735. 10.1007/s11136-008-9338-1, 2424212, 18427951.
13. Irwin DE, Varni JW, Yeatts K, DeWalt DA. Cognitive interviewing methodology in the development of a pediatric item bank: a patient reported outcomes measurement information system (PROMIS) study. Health and Quality of Life Outcomes 2009, 7.
14. Reeve BB, Hays RD, Bjorner JB, Cook KF, Crane PK, Teresi JA, Thissen D, Revicki DA, Weiss DJ, Hambleton RK, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 2007, 45(5 Suppl 1):S22-31.
15. Flood EM, Beusterien KM, Amonkar MM, Jurgensen CH, Dewit OE, Kahl LP, Matza LS. Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires*. Curr Med Res Opin 2008, 24(12):3369-3381. 10.1185/03007990802536900, 19032119.
16. Ronen GM, Rosenbaum P, Law M, Streiner DL. Health-related quality of life in childhood disorders: a modified focus group technique to involve children. Quality of Life Research 2001, 10(1):71-79. 10.1023/A:1016659917227, 11508477.
17. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007, 19(6):349-357. 10.1093/intqhc/mzm042, 17872937.
18. Pentiuk S, Putnam PE, Collins MH, Rothenberg ME. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009, 48(2):152-160. 10.1097/MPG.0b013e31817f0197, 2699182, 19179876.
19. Schurman JV, Wu YP, Grayson P, Friesen CA. A pilot study to assess the efficacy of biofeedback-assisted relaxation training as an adjunct treatment for pediatric functional dyspepsia associated with duodenal eosinophilia. J Pediatr Psychol 2010, 35(8):837-847. 10.1093/jpepsy/jsq010, 20185416.
20. Southwell BR, Clarke MCC, Chase JW, Gibb S, Hutson JM. Improvement of quality of life in children with slow transit constipation after treatment with transcutaneous electrical stimulation. J Pediatr Surg 2009, 44(6):1268-1273. 10.1016/j.jpedsurg.2009.02.031, 19524752.
21. Nuboer R, Borsboom GJJM, Zoethout JA, Koot HM, Bruining J. Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison. Pediatr Diabetes 2008, 9(4):291-296. 10.1111/j.1399-5448.2008.00396.x, 18466210.
22. Schwimmer JB, Middleton MS, Deutsch R, Lavine JE. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2005, 21(7):871-879. 10.1111/j.1365-2036.2005.02420.x, 15801922.
23. Zeller MH, Reiter-Purtill J, Ratcliff MB, Inge TH, Noll JG. Two-year trends in psychosocial functioning after adolescent Roux-en-Y gastric bypass. Surg Obes Relat Dis 2011,
24. Parekh AD, Thomas JC, Trusler L, Ankerst DP, Deshpande JK, Adams MC, Pope J, Brock JW. Prospective evaluation of health related quality of life for pediatric patients with ureteropelvic junction obstruction. J Urol 2008, 180(5):2171-2175. discussion 2175-2176, 10.1016/j.juro.2008.07.064, 18804796.
25. Thornburg CD, Calatroni A, Panepinto JA. Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. J Pediatr Hematol Oncol 2011, 33(4):251-254. 10.1097/MPH.0b013e3182114c54, 21516020.
26. Fullerton G, Tyler C, Johnston CA, Vincent JP, Harris GE, Foreyt JP. Quality of life in Mexican-American children following a weight management program. Obesity (Silver Spring) 2007, 15(11):2553-2556.
27. McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, Enders FB, Fredericksen M, Abdalla AA, Khan Y, et al. The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia 2010, 25(3):221-230. 10.1007/s00455-009-9246-8, 19856027.
28. Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010, 139(2):418-429. 10.1053/j.gastro.2010.05.001, 20457157.
29. Walsh GM. Reslizumab for pediatric eosinophilic esophagitis. Immunotherapy-Uk 2010, 2(4):461-465.